SEI Investments’s Aerie Pharmaceuticals AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-49,059
| Closed | -$743K | – | 2735 |
|
|
2022
Q3 | $743K | Buy |
49,059
+1,149
| +2% | +$13.4K | ﹤0.01% | 1917 |
|
|
2022
Q2 | $353K | Buy |
47,910
+1,526
| +3% | +$10.8K | ﹤0.01% | 2254 |
|
|
2022
Q1 | $415K | Buy |
46,384
+16,914
| +57% | +$130K | ﹤0.01% | 2164 |
|
|
2021
Q4 | $201K | Sell |
29,470
-1,529
| -5% | -$16K | ﹤0.01% | 2471 |
|
|
2021
Q3 | $345K | Buy |
30,999
+784
| +3% | +$11.5K | ﹤0.01% | 2256 |
|
|
2021
Q2 | $479K | Buy |
30,215
+2,163
| +8% | +$37.1K | ﹤0.01% | 2113 |
|
|
2021
Q1 | $492K | Buy |
28,052
+2,647
| +10% | +$45.7K | ﹤0.01% | 2030 |
|
|
2020
Q4 | $338K | Buy |
25,405
+2,247
| +10% | +$27.2K | ﹤0.01% | 2152 |
|
|
2020
Q3 | $271K | Sell |
23,158
-55,287
| -70% | -$673K | ﹤0.01% | 2136 |
|
|
2020
Q2 | $1.16M | Buy |
78,445
+5,244
| +7% | +$77.6K | ﹤0.01% | 1497 |
|
|
2020
Q1 | $986K | Buy |
73,201
+25,329
| +53% | +$481K | ﹤0.01% | 1474 |
|
|
2019
Q4 | $1.16M | Buy |
+47,872
| New | +$991K | ﹤0.01% | 1587 |
|
|
2019
Q3 | – | Sell |
-7,082
| Closed | -$207K | – | 2443 |
|
|
2019
Q2 | $207K | Buy |
7,082
+2,575
| +57% | +$99.2K | ﹤0.01% | 2241 |
|
|
2019
Q1 | $213K | Sell |
4,507
-14,288
| -76% | -$629K | ﹤0.01% | 2259 |
|
|
2018
Q4 | $825K | Buy |
18,795
+12,982
| +223% | +$609K | ﹤0.01% | 1592 |
|
|
2018
Q3 | $359K | Buy |
5,813
+1,000
| +21% | +$64.3K | ﹤0.01% | 1752 |
|
|
2018
Q2 | $325K | Sell |
4,813
-111
| -2% | -$6.21K | ﹤0.01% | 1913 |
|
|
2018
Q1 | $267K | Buy |
4,924
+784
| +19% | +$43.8K | ﹤0.01% | 1788 |
|
|
2017
Q4 | $247K | Buy |
4,140
+1,035
| +33% | +$62.8K | ﹤0.01% | 1851 |
|
|
2017
Q3 | $151K | Sell |
3,105
-11,940
| -79% | -$651K | ﹤0.01% | 1964 |
|
|
2017
Q2 | $790K | Buy |
15,045
+15,017
| +53,632% | +$699K | ﹤0.01% | 1498 |
|
|
2017
Q1 | $1K | Sell |
28
-11,800
| -100% | -$526K | ﹤0.01% | 2856 |
|
|
2016
Q4 | $448K | Buy |
11,828
+11,800
| +42,143% | +$446K | ﹤0.01% | 1610 |
|
|
2016
Q3 | $1K | Sell |
28
-1
| -3% | -$22 | ﹤0.01% | 2775 |
|
|
2016
Q2 | $0 | Buy |
29
+28
| +2,800% | +$453 | ﹤0.01% | 2794 |
|
|
2016
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 2684 |
|
|
2015
Q4 | $0 | Sell |
1
-35,483
| -100% | -$828K | ﹤0.01% | 2738 |
|
|
2015
Q3 | $629K | Buy |
35,484
+35,030
| +7,716% | +$634K | 0.01% | 1198 |
|
|
2015
Q2 | $8K | Sell |
454
-22
| -5% | -$403 | ﹤0.01% | 1954 |
|
|
2015
Q1 | $15K | Sell |
476
-49
| -9% | -$1.42K | ﹤0.01% | 1856 |
|
|
2014
Q4 | $16K | Buy |
+525
| New | +$13.3K | ﹤0.01% | 1833 |
|
SEI Investments's AERI Position: Q4 2022 in Review
SEI Investments sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 49,059 shares — an estimated $743K sold.
SEI Investments first reported a position in AERI in Q4 2014 and held it in 31 quarters. The position peaked at $1.16M in Q4 2019. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.
- SEI Investments reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
- SEI Investments sold 49,059 Aerie Pharmaceuticals shares in Q4 2022, an estimated $743K.
- SEI Investments first reported a position in Aerie Pharmaceuticals in Q4 2014 and held it in 31 quarters.
- SEI Investments's Aerie Pharmaceuticals position peaked at $1.16M in Q4 2019.
- 0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.
Based on SEI Investments's 13F filing for Q4 2022, filed 10 Feb 2023.